Integrating Discovery, Improving Efficiency

RubrYc Therapeutics Discovery-Stage Pipeline

RubrYc’s pipeline of products includes several proprietary therapeutic antibody programs targeting unique epitopes for oncology and immunology indications.

RTX-001 T-Cell Checkpoint Antagonist

Immuno-Oncology

RTX-002 T-Cell Checkpoint Agonist

Autoimmune

RTX-003 Tumor-targeted T-Cell Activation

Immuno-Oncology

RTX-004 Macrophage Targeting

Autoimmune